Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer - Concepedia

Concepedia

Publication | Closed Access

Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer

51

Citations

35

References

2017

Year

Saranrat Wittayanukorn, Jingjing Qian, Salisa C. Westrick, Nedret Billor, Brandon Johnson, Richard A. Hansen

American Journal of Clinical Oncology

Abstract

ACEIs/BBs show favorable effects on preventing cardiotoxicity and improving survival in female breast cancer patients undergoing trastuzumab/anthracycline treatment.

References

	Year	Citations

Page 1